נוילפטיל 10 מ"ג ישראל - עברית - Ministry of Health

נוילפטיל 10 מ"ג

sanofi - aventis israel ltd - pericyazine 10 mg - capsules - periciazine - for psychotic disorders.

נוילפטיל טיפות ישראל - עברית - Ministry of Health

נוילפטיל טיפות

sanofi - aventis israel ltd - pericyazine 40 mg/ml - drops - periciazine - for psychotic disorders.

יאז פלוס ישראל - עברית - Ministry of Health

יאז פלוס

bayer israel ltd - drospirenone; ethinylestradiol as betadex clathrate; levomefolate calcium; levomefolate calcium - טבליות מצופות פילם - levomefolate calcium 0.451 mg; ethinylestradiol as betadex clathrate 0.02 mg; drospirenone 3 mg; levomefolate calcium 0.451 mg - estradiol, combinations

יאז ישראל - עברית - Ministry of Health

יאז

bayer israel ltd - drospirenone; ethinylestradiol - טבליות מצופות פילם - drospirenone 3 mg; ethinylestradiol 0.02 mg - drospirenone and estrogen - drospirenone and estrogen - - oral contraception. - treatment of moderate acne vulgaris in women who seek oral contraception. - treatment of symptoms of premenstrual dysphoric disorder (pmdd ) in women who have chosen oral contraceptives as their method of birth control. the efficacy of yaz for pmdd was not assessed beyond 3 cycles. yaz has not been evaluated for treatment of pms ( premenstrual syndrome ).

ווטריינט 200 מג ישראל - עברית - Ministry of Health

ווטריינט 200 מג

novartis israel ltd - pazopanib as hydrochloride - טבליות מצופות פילם - pazopanib as hydrochloride 200 mg - pazopanib - pazopanib - renal cell carcinoma (rcc)votrient is indicated in adults for the first line treatment of advanced renal cell carcinoma (rcc) and for patients who have received prior cytokine therapy for advanced disease.soft tissue sarcoma (sts)votrient is indicated for the treatment of adult patients with selective subtypes of advanced soft tissue sarcoma (sts) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.

ווטריינט 400 מג ישראל - עברית - Ministry of Health

ווטריינט 400 מג

novartis israel ltd - pazopanib as hydrochloride - טבליות מצופות פילם - pazopanib as hydrochloride 400 mg - pazopanib - pazopanib - renal cell carcinoma (rcc)votrient is indicated in adults for the first line treatment of advanced renal cell carcinoma (rcc) and for patients who have received prior cytokine therapy for advanced disease.soft tissue sarcoma (sts)votrient is indicated for the treatment of adult patients with selective subtypes of advanced soft tissue sarcoma (sts) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.

וטבנציד וטרינרי ישראל - עברית - Ministry of Health

וטבנציד וטרינרי

a.veterinary supply ltd - praziquantel - תמיסה להזרקה - praziquantel 56.8 mg/ml

דרונטל טבליות לחתול וטרינרי ישראל - עברית - Ministry of Health

דרונטל טבליות לחתול וטרינרי

lidorr elements ltd - praziquantel; pyrantel embonate - טבליה - praziquantel 20 mg; pyrantel embonate 230 mg

פרזיטל וטרינרי טבליות לחתולים ישראל - עברית - Ministry of Health

פרזיטל וטרינרי טבליות לחתולים

a.l. medi-market ltd. - praziquantel; pyrantel embonate - טבליה - praziquantel 20 mg; pyrantel embonate 230 mg

אי-קווסט פרמוקס וטרינרי ישראל - עברית - Ministry of Health

אי-קווסט פרמוקס וטרינרי

zoetis israel holding b.v., israel - moxidectin; praziquantel - ג'ל - moxidectin 1.95 %w/w; praziquantel 12.17 %w/w - equest pramox veterinary is indicated for treatment of mixed cestodes and nematodes or arthropods infections, caused by moxidectin and praziquantel sensitive strains of : large strongyles, small strongyles (adults and intraluminal larval stages), ascarids and other species, tapeworm (adults). the egg reappearance period of small strongyles is 90 days. the product is effective against (developing) intramucosal l4 stages of small strongyles. at 8 weeks after treatment, early (hypobiotic) el3 stages of small strongyles are eliminated.